The Oncosearch | Oncotarget

ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer Research Paper

Qiongrong Chen, Shumei Song, Shaozhong Wei, Bin Liu, Soichiro Honjo, Ailing Scott, Jiankang Jin, Lang Ma, Haitao Zhu, Heath D. Skinner, Randy L. Johnson, Jaffer A. Ajani

Published Jul 17, 2015 · Vol. 6, No. 28 · pp. 25883-25896

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma Research Paper

Charlotte KervoÃ«len, Emmanuelle MÃ©noret, Patricia Gomez-Bougie, RÃ©gis Bataille, Catherine Godon, SÃ©verine Marionneau-Lambot, Philippe Moreau, Catherine Pellat-Deceunynck, Martine Amiot

Published Jul 16, 2015 · Vol. 6, No. 29 · pp. 26922-26934

A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2 Research Paper

Ammara Abdullah, Sanam Sane, Kate A. Branick, Jessica L Freeling, Hongmin Wang, Dong Zhang, Khosrow Rezvani

Published Jul 11, 2015 · Vol. 6, No. 27 · pp. 23561-23581

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma Research Paper

Meng Li, Lixing Zhang, Chao Ge, Lijuan Chen, Tao Fang, Hong Li, Hua Tian, Junxi Liu, Taoyang Chen, Guoping Jiang, Haiyang Xie, Ying Cui, Ming Yao, Jinjun Li

Published Jul 10, 2015 · Vol. 6, No. 28 · pp. 25149-25160

Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells Priority Research Paper

Lucilla Bongiorno-Borbone, Arianna Giacobbe, Mirco Compagnone, Adriana Eramo, Ruggero De Maria, Angelo Peschiaroli, Gerry Melino

Published Jul 1, 2015 · Vol. 6, No. 19 · pp. 16926-16938

Oncogenic cancer/testis antigens: prime candidates for immunotherapy Review

Morten F. Gjerstorff, Mads H. Andersen, Henrik J. Ditzel

Published Jun 30, 2015 · Vol. 6, No. 18 · pp. 15772-15787

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Research Paper

Cinzia Fionda, Maria Pia Abruzzese, Alessandra Zingoni, Francesca Cecere, Elisabetta Vulpis, Giovanna Peruzzi, Alessandra Soriani, Rosa Molfetta, Rossella Paolini, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Angela Santoni, Marco Cippitelli

Published Jun 23, 2015 · Vol. 6, No. 27 · pp. 23609-23630

Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo Research Paper

Sheng-Huei Yang, Hung-Yun Lin, Vincent H.S. Chang, Chien-Chung Chen, Yun-Ru Liu, Jinghan Wang, Keqiang Zhang, Xiaoqing Jiang, Yun Yen

Published Jun 23, 2015 · Vol. 6, No. 27 · pp. 23857-23873

Keywords: Cholangiocarcinomas, Combination therapy, Lovastatin, Gefitinib

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity Research Paper

De-Gang Song, Qunrui Ye, Mathilde Poussin, Lin Liu, Mariangela Figini, Daniel J. Powell Jr.

Published Jun 19, 2015 · Vol. 6, No. 25 · pp. 21533-21546

Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* Research Paper

David M. Goldenberg, Thomas M. Cardillo, Serengulam V. Govindan, Edmund A. Rossi, Robert M. Sharkey

Published Jun 18, 2015 · Vol. 6, No. 26 · pp. 22496-22512

AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer Priority Research Paper

Teraneh Z. Jhaveri, Juhyung Woo, Xiaobin Shang, Ben Ho Park, Edward Gabrielson

Published Jun 15, 2015 · Vol. 6, No. 17 · pp. 14754-14765

The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells Research Paper

Ying Gao, Renbin Huang, Yixuan Gong, Hyo Sim Park, Qingwei Wen, Nadin Marwan Almosnid, Uma D. Chippada-Venkata, Najlaa Abdulrhman Hosain, Eric Vick, Anthony Farone, Elliot Altman

Published Jun 15, 2015 · Vol. 6, No. 27 · pp. 24304-24319

Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F Research Paper

Spela Magister, Han-Ching Tseng, Vickie T. Bui, Janko Kos, Anahid Jewett

Published Jun 13, 2015 · Vol. 6, No. 26 · pp. 22310-22327

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy Priority Research Paper

Erika Vacchelli, Michaela Semeraro, David P. Enot, Kariman Chaba, Vichnou Poirier Colame, Peggy Dartigues, Aurelie Perier, Irene Villa, Sylvie Rusakiewicz, Caroline Gronnier, Diane GoÃ©rÃ©, Christophe Mariette, Laurence Zitvogel, Guido Kroemer

Published Jun 10, 2015 · Vol. 6, No. 25 · pp. 20840-20850

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer Research Paper

Christophe Deben, An Wouters, Ken Op de Beeck, Jolien van Den Bossche, Julie Jacobs, Karen Zwaenepoel, Marc Peeters, Jan Van Meerbeeck, Filip Lardon, Christian Rolfo, Vanessa Deschoolmeester, Patrick Pauwels

Published Jun 10, 2015 · Vol. 6, No. 26 · pp. 22666-22679

Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells Research Paper

Silvia Bruno, Bernardetta Ledda, Claudya Tenca, Silvia Ravera, Anna Maria Orengo, Andrea Nicola Mazzarello, Elisa Pesenti, Salvatore Casciaro, Omar Racchi, Fabio Ghiotto, Cecilia Marini, Gianmario Sambuceti, Andrea DeCensi, Franco Fais

Published Jun 5, 2015 · Vol. 6, No. 26 · pp. 22624-22640

Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001 Research Paper

Shoucheng Ning, Thillai Veerapazham Sekar, Jan Scicinski, Bryan Oronsky, Donna M. Peehl, Susan J. Knox, Ramasamy Paulmurugan

Published Jun 4, 2015 · Vol. 6, No. 25 · pp. 21547-21556

Novel agents for advanced pancreatic cancer Review

Akintunde Akinleye, Chaitanya Iragavarapu, Muhammad Furqan, Shundong Cang, Delong Liu

Published Jun 3, 2015 · Vol. 6, No. 37 · pp. 39521-39537

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy Research Paper

Mohammad T. Malik, Martin G. Oâ€™Toole, Lavona K. Casson, Shelia D. Thomas, Gina T. Bardi, Elsa Merit Reyes-Reyes, Chin K. Ng, Kyung A. Kang, Paula J. Bates

Published Jun 3, 2015 · Vol. 6, No. 26 · pp. 22270-22281

Identification and characterization of RET fusions in advanced colorectal cancer Research Paper

Anne-France Le Rolle, Samuel J. Klempner, Christopher R. Garrett, Tara Seery, Eric M. Sanford, Sohail Balasubramanian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Vi K. Chiu

Published May 30, 2015 · Vol. 6, No. 30 · pp. 28929-28937

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer Research Paper

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma Research Paper

A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2 Research Paper

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma Research Paper

Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells Priority Research Paper

Oncogenic cancer/testis antigens: prime candidates for immunotherapy Review

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Research Paper

Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo Research Paper

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity Research Paper

Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* Research Paper

AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer Priority Research Paper

The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells Research Paper

Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F Research Paper

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy Priority Research Paper

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer Research Paper

Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells Research Paper

Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001 Research Paper

Novel agents for advanced pancreatic cancer Review

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy Research Paper

Identification and characterization of RET fusions in advanced colorectal cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer Research Paper

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma Research Paper

A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2 Research Paper

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma Research Paper

Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells Priority Research Paper

Oncogenic cancer/testis antigens: prime candidates for immunotherapy Review

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Research Paper

Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo Research Paper

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity Research Paper

Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* Research Paper

AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer Priority Research Paper

The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells Research Paper

Regulation of split anergy in natural killer cells by inhibition of cathepsins C and H and cystatin F Research Paper

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy Priority Research Paper

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer Research Paper

Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells Research Paper

Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001 Research Paper

Novel agents for advanced pancreatic cancer Review

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy Research Paper

Identification and characterization of RET fusions in advanced colorectal cancer Research Paper